- Home
- PTN vs SABS Comparison
PTN vs SABS Comparison
Compare PTN & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTN
- SABS
- Stock Information
- Founded
- PTN 1986
- SABS 2014
- Country
- PTN United States
- SABS United States
- Employees
- PTN N/A
- SABS N/A
- Industry
- PTN Biotechnology: Pharmaceutical Preparations
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- PTN Health Care
- SABS Health Care
- Exchange
- PTN Nasdaq
- SABS Nasdaq
- Market Cap
- PTN N/A
- SABS 19.0M
- IPO Year
- PTN 1993
- SABS N/A
- Fundamental
- Price
- PTN $0.54
- SABS $1.25
- Analyst Decision
- PTN Strong Buy
- SABS Strong Buy
- Analyst Count
- PTN 1
- SABS 5
- Target Price
- PTN $7.00
- SABS $11.40
- AVG Volume (30 Days)
- PTN 904.9K
- SABS 38.1K
- Earning Date
- PTN 05-14-2025
- SABS 05-19-2025
- Dividend Yield
- PTN N/A
- SABS N/A
- EPS Growth
- PTN N/A
- SABS N/A
- EPS
- PTN N/A
- SABS N/A
- Revenue
- PTN $350,000.00
- SABS $1,322,410.00
- Revenue This Year
- PTN N/A
- SABS N/A
- Revenue Next Year
- PTN N/A
- SABS $25.00
- P/E Ratio
- PTN N/A
- SABS N/A
- Revenue Growth
- PTN N/A
- SABS N/A
- 52 Week Low
- PTN $0.46
- SABS $1.11
- 52 Week High
- PTN $2.88
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- PTN 28.90
- SABS 31.17
- Support Level
- PTN $0.68
- SABS $1.11
- Resistance Level
- PTN $0.84
- SABS $1.80
- Average True Range (ATR)
- PTN 0.08
- SABS 0.16
- MACD
- PTN -0.02
- SABS -0.01
- Stochastic Oscillator
- PTN 20.22
- SABS 18.42
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.